Avadel Pharmaceuticals (AVDL) News Today

$15.49
-0.45 (-2.82%)
(As of 05/17/2024 08:53 PM ET)
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Consensus Rating of "Buy" from Analysts
Avadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) has received a consensus rating of "Buy" from the six research firms that are covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month price target among bro
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Sees Significant Decrease in Short Interest
Avadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) was the target of a large decrease in short interest in April. As of April 30th, there was short interest totalling 4,800,000 shares, a decrease of 54.8% from the April 15th total of 10,610,000 shares. Based on an average trading volume of 1,250,000 shares, the days-to-cover ratio is currently 3.8 days.
Avadel Pharmaceuticals (NASDAQ:AVDL) Trading 5.2% Higher on Analyst Upgrade
Avadel Pharmaceuticals (NASDAQ:AVDL) Stock Price Up 5.2% on Analyst Upgrade
Q4 2024 EPS Estimates for Avadel Pharmaceuticals plc (NASDAQ:AVDL) Reduced by Leerink Partnrs
Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Investment analysts at Leerink Partnrs decreased their Q4 2024 earnings per share (EPS) estimates for shares of Avadel Pharmaceuticals in a report issued on Wednesday, May 8th. Leerink Partnrs analyst M. Goodman now expects that the company
Avadel Pharmaceuticals (NASDAQ:AVDL) Price Target Raised to $27.00
HC Wainwright lifted their target price on shares of Avadel Pharmaceuticals from $25.00 to $27.00 and gave the company a "buy" rating in a research note on Thursday.
Avadel Pharmaceuticals (NASDAQ:AVDL) Issues Earnings Results
Avadel Pharmaceuticals (NASDAQ:AVDL - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.25) by ($0.05). The business had revenue of $27.18 million for the quarter, compared to analyst estimates of $25.89 million. The company's revenue for the quarter was up 2617.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.48) EPS.
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Down 7.3% on Disappointing Earnings
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Down 7.3% on Disappointing Earnings
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Down to $18.18
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Down to $18.18
Avadel Pharmaceuticals (NASDAQ:AVDL) Receives Buy Rating from Needham & Company LLC
Needham & Company LLC reiterated a "buy" rating and set a $22.00 price objective on shares of Avadel Pharmaceuticals in a research note on Wednesday.
Avadel Pharmaceuticals (AVDL) to Release Quarterly Earnings on Wednesday
Avadel Pharmaceuticals (NASDAQ:AVDL) will be releasing earnings before the market opens on Wednesday, May 8, Zacks reports.
Avadel Pharmaceuticals (NASDAQ:AVDL) Reaches New 1-Year High at $18.97
Avadel Pharmaceuticals (NASDAQ:AVDL) Sets New 12-Month High at $18.97
Vivo Capital LLC Sells 124,329 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)
Vivo Capital LLC reduced its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 3.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,972,099 shares of the company's stock aft
Avadel Pharmaceuticals plc
106,475 Shares in Avadel Pharmaceuticals plc (NASDAQ:AVDL) Purchased by Investors Asset Management of Georgia Inc. GA ADV
Investors Asset Management of Georgia Inc. GA ADV acquired a new position in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 106,
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Down 3.4%
Avadel Pharmaceuticals (NASDAQ:AVDL) Stock Price Down 3.4%
Avadel Pharmaceuticals (NASDAQ:AVDL) Hits New 1-Year High at $18.08
Avadel Pharmaceuticals (NASDAQ:AVDL) Reaches New 12-Month High at $18.08
Avadel Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:AVDL)
Avadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) saw unusually large options trading activity on Tuesday. Stock traders purchased 4,733 call options on the company. This represents an increase of approximately 92% compared to the typical volume of 2,463 call options.
Avadel Pharmaceuticals plc (AVDL)
Avadel Pharmaceuticals (NASDAQ:AVDL) Trading 5.9% Higher
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Up 5.9%
Traders Buy Large Volume of Put Options on Avadel Pharmaceuticals (NASDAQ:AVDL)
Avadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) saw some unusual options trading activity on Thursday. Traders bought 3,934 put options on the company. This is an increase of 73% compared to the average daily volume of 2,276 put options.
Avadel Pharmaceuticals' (AVDL) "Buy" Rating Reiterated at Needham & Company LLC
Needham & Company LLC reissued a "buy" rating and issued a $22.00 price objective on shares of Avadel Pharmaceuticals in a research report on Tuesday.
Avadel Pharmaceuticals (NASDAQ:AVDL) Share Price Passes Above 200-Day Moving Average of $13.24
Avadel Pharmaceuticals (NASDAQ:AVDL) Stock Crosses Above 200-Day Moving Average of $13.24
AVDL Apr 2024 15.000 call
AVDL Apr 2024 25.000 call
AVDL Apr 2024 10.000 put
Get Avadel Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter.

Shocking: One AI startup's revenue could surge 4,735% (Ad)

Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.

Click here to discover the AI chip company

AVDL Media Mentions By Week

AVDL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AVDL
News Sentiment

0.53

0.42

Average
Medical
News Sentiment

AVDL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AVDL Articles
This Week

11

3

AVDL Articles
Average Week

Get Avadel Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:AVDL) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners